Sun Pharma News Today

Medical leave is weighing on stocks. Beatingand properties expectations, the largest stock showing that resilience despite weaker earnings. It is 4 00 a. M. In london. Bloombergcome to markets middle east. You mentioned those earnings in asia. We are seeing not just earnings, but what has happened in the u. S. The dollarmy index was a gaining before. It is sharing those gains in the asian session. We are seeing others gain as well. Crude losing 7 10 of 1 . U. S. Is showing expanding stockpiles. ...

Ninety five point five percent of the electorate in crimea offensive to join the rush to see that comes up to fifty percent of the set being counted the self proclaimed leader in crimea the pro kremlin said any action to address the crowd we are going back and write me at the scene russia. Ray covers you we did it together thanks to you feel country jokes to pull. Thanks to rush it. The russian peoples support. On the support of its president. Nobody can take away all but during the day. I feel ...

As referendum have been considered. The complete preliminary ballot and showed up twenty six point seven seven percent of voters in crimea elected to join russia it is to choose the court increased the number of versions of the crummy a referendum as one milliontwo hundred and seventy four thousand one to say this eighty three point one percent of them the Prime Minister of crummy as Regional Assembly range that the election which is not recognized what he gets because they dont consider the pro...

Aat better way to launch with 4 billion deal in the generic drugs industry. John is here with the details. We are talking about ranbaxy. Thats right. Clearly, shares were rising in that region, but sun pharma agreed to by ranbaxy at 4. 1 billion. Here,sting, the movement the Japanese Company owning a large part of ranbaxy. It is a done deal essentially . Yes. In 2008, the Company Bought ranbaxy for for for 1 billion. With u. S. Ssues authorities. It has been a problem child. Ranbaxy, for plans t...

Pharma sector has witnessed a fresh breakout from the consolidation to record high levels and Sun Pharma is offering a fresh buying opportunity

Suzlon Energy, a key player in Indias renewable energy sector, saw a remarkable turnaround in FY24. The company became debt-free, increased its order book, and revamped leadership under CEO JP Chalasani.

The Navhind Times ePaper | Covering Goa Since 1963

A leading healthcare retail chain MedPlus reports healthy profits, we profile the healthcare system in India, the world's most populous country

India is well positioned to meet this demand, says Uday Bhaskar, Director General of the Pharmaceuticals Export Promotion Council (Pharmexcil).

ICRA assigns A1+ rating to Vedanta's commercial paper, JioFinance launches super-app, Orient Electric appoints new MD, Sun Pharma recalls products.